A randomized trial of adjunct testosterone for cancer‐related muscle loss in men and women

Abstract

In patients with advanced cancer undergoing the early phase of standard of care therapy, adjunct testosterone improved lean body mass and was also associated with increased quality of life, and physical activity compared with placebo.